Astrazeneca Pharma India standalone net profit rises 3322.50% in the September 2017 quarter
Sales rise 18.88% to Rs 164.26 crore
Net profit of Astrazeneca Pharma India rose 3322.50% to Rs 27.38 crore in the quarter ended September 2017 as against Rs 0.80 crore during the previous quarter ended September 2016. Sales rose 18.88% to Rs 164.26 crore in the quarter ended September 2017 as against Rs 138.17 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales164.26138.17 19 OPM %21.702.29 -PBDT38.145.05 655 PBT34.390.99 3374 NP27.380.80 3323Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 07 2017 | 4:18 PM IST